Abstract
An acetylated polypeptide corresponding to residues 2-26 of human lipocortin 1 was synthesized and the anti-inflammatory activity assessed in three models of acute inflammation in rat and mouse. In the carrageenin rat paw oedema test, the peptide produced a maximal inhibition of approximately 41% at the 3 h time point with a 10 micrograms dose. When rat paw oedema was induced by the injection of venom phospholipase A2, the peptide produced a significant inhibition (31%) at the top dose of 20 micrograms per paw. In the mouse air-pouch model, systemic treatment with the peptide produced a dramatic reduction in cytokine-induced leukocyte migration with an ID50 of approximately 40 micrograms per mouse. The N-terminal peptide 2-26 shares the actions of lipocortin 1 in these acute models of inflammation.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carey F., Forder R., Edge M. D., Greene A. R., Horan M. A., Strijbos P. J., Rothwell N. J. Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol. 1990 Aug;259(2 Pt 2):R266–R269. doi: 10.1152/ajpregu.1990.259.2.R266. [DOI] [PubMed] [Google Scholar]
- Chuah S. Y., Pallen C. J. Calcium-dependent and phosphorylation-stimulated proteolysis of lipocortin I by an endogenous A431 cell membrane protease. J Biol Chem. 1989 Dec 15;264(35):21160–21166. [PubMed] [Google Scholar]
- Cirino G., Flower R. J., Browning J. L., Sinclair L. K., Pepinsky R. B. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature. 1987 Jul 16;328(6127):270–272. doi: 10.1038/328270a0. [DOI] [PubMed] [Google Scholar]
- Cirino G., Flower R. J. Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins. 1987 Jul;34(1):59–62. doi: 10.1016/0090-6980(87)90262-0. [DOI] [PubMed] [Google Scholar]
- Cirino G., Peers S. H., Flower R. J., Browning J. L., Pepinsky R. B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A. 1989 May;86(9):3428–3432. doi: 10.1073/pnas.86.9.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goulding N. J., Luying P., Guyre P. M. Characteristics of lipocortin 1 binding to the surface of human peripheral blood leucocytes. Biochem Soc Trans. 1990 Dec;18(6):1237–1238. doi: 10.1042/bst0181237. [DOI] [PubMed] [Google Scholar]
- Notsu Y., Namiuchi S., Hattori T., Matsuda K., Hirata F. Inhibition of phospholipases by Met-Leu-Phe-Ile-Leu-Ile-Lys-Arg-Ser-Arg-His-Phe, C terminus of middle-sized tumor antigen. Arch Biochem Biophys. 1985 Jan;236(1):195–204. doi: 10.1016/0003-9861(85)90619-8. [DOI] [PubMed] [Google Scholar]
- Relton J. K., Strijbos P. J., O'Shaughnessy C. T., Carey F., Forder R. A., Tilders F. J., Rothwell N. J. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med. 1991 Aug 1;174(2):305–310. doi: 10.1084/jem.174.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]